Delivery Order SPE2DB22D2206-SPE2DB25FJM06
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Onfil 10 mg tablets (100 count) with a ceiling value of $3,064.78. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of July 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, on August 18, 2025, for an amount of $39,640.32 under a firm fixed-price contract. This non-set-aside award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract is scheduled for completion by August 19, 2025,...
- The Defense Logistics Agency awarded a delivery order valued at $9,737.35 to AmerisourceBergen Drug Corp for Onfil 10 mg tablets (100 count) on August 11, 2025, with completion scheduled for August 12, 2025. This non-set-aside contract employs firm fixed pricing under a delivery order contract type and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a $5,525.16 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Onfil 10 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with performance through July 29, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 31, 2025, for Onfil 10 mg tablets (100-count units) with a ceiling value of $11,281.66. This firm fixed-price delivery order, which represents a non-competitive set-aside contract, is scheduled for ultimate completion by August 1, 2025, with performance occurring at the awardee's Conshohocken facility. The contract was issued as a child order...
- This delivery order, valued at $27,224.00, was awarded to AmerisourceBergen Drug Corp on August 1, 2025, with an ultimate completion date of August 4, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The award was made on a non-competitive, firm fixed price basis by the Defense Logistics Agency's...
- This delivery order, issued on July 28, 2025, awards AmerisourceBergen Drug Corp a contract valued at $10,806.66 for pharmaceutical and medical supply delivery. The award is a child delivery order under a larger Indefinite Delivery Contract vehicle and utilizes firm fixed pricing with no set-aside designation. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. The funding agency is the Defense...
- This delivery order, valued at $8,630.28, was awarded on July 21, 2025, to AmerisourceBergen Drug Corp for pharmaceutical supply through the Defense Logistics Agency's Medical Supply Chain division. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle that runs through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $58,103.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 5, 2025, with an ultimate completion date of the same day. This competitive, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be performed at the contractor's corporate...
- This delivery order, valued at $1,040.74, was awarded on August 15, 2025, to AmerisourceBergen Drug Corp for pharmaceutical and medical supply provision under a Defense Logistics Agency (DLA) contract. The award was issued without a set-aside designation on a firm fixed-price basis, with performance occurring at the contractor's Conshohocken, Pennsylvania location. Funding originated from the Defense Medical Supply Chain, reflecting ongoing federal procurement needs for pharmaceutical products...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJM06Delivery Order
This delivery order, valued at $1,841.72, was awarded on August 18, 2025, to AmerisourceBergen Drug Corp for the supply of Onfil 10 mg tablets (100-count units). The contract was funded by the Defense Logistics Agency (DLA), a defense agency component, and utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance of this delivery order is based in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp supplies a comprehensive portfolio of medications and medical commodities to support military healthcare systems. The underlying IDC serves as a global pharmaceutical support vehicle enabling delivery of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to support federal healthcare programs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/18/25 |